Method of treating endothelial injury

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 33/24 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2265547

The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjuction with the administration of chemotherapeutic agents is described.

Cette invention concerne l'utilisation d'érythropoïétine (EPO) humaine pour prévenir ou traiter les lésions endothéliales dues à la chimiothérapie, à la radiothérapie, à des traumatismes mécaniques ou à un état pathologique qui endommage l'endothélium (tel que l'inflammation, les maladies cardiaques ou le cancer). Dans cette invention on utilise l'érythropoïétine en conjonction avec l'administration d'agents chimiothérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating endothelial injury does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating endothelial injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating endothelial injury will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1558986

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.